Oculis Holding AG (OCS) Common Equity (2021 - 2026)

Oculis Holding AG (OCS) recorded quarterly Common Equity of $251.1 million in Q1 2026, up 2.37% quarter-over-quarter from $245.3 million in Q4 2025, and up 38.83% on a YoY basis from $180.9 million in Q1 2025.

Oculis Holding AG (OCS) Common Equity (2021 - 2026) Analysis & Trends

Oculis Holding AG's Common Equity history runs 6 years deep, the most recent figure standing at $251.1 million for Q1 2026.

  • In Q1 2026, Common Equity rose 38.83% year-over-year to $251.1 million; the TTM figure through Mar 2026 stood at $251.1 million (up 38.83% YoY), while the FY2025 annual figure was $245.3 million, up 192.85% from the prior year.
  • Common Equity was $251.1 million for Q1 2026 at Oculis Holding AG, up from $245.3 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $251.1 million in Q1 2026 to a low of -$101.7 million in Q4 2022.
  • Historically, Common Equity has averaged $128.9 million across 5 years, with a median of $124.8 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Common Equity sank 53.87% in 2022, then soared 203.88% in 2023.
  • A 5-year view of Common Equity shows it stood at -$101.7 million in 2022, then jumped by 203.88% to $105.7 million in 2023, then declined by 20.72% to $83.8 million in 2024, then surged by 192.85% to $245.3 million in 2025, then increased by 2.37% to $251.1 million in 2026.
  • The last three Common Equity figures came in at $251.1 million (Q1 2026), $245.3 million (Q4 2025), and $163.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 35.63 Mn
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -1.42 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 14.38 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 13.21 Mn
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 11.87 Mn
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 19.36 Bn
9 Abivax 90.15 Bn 90.15 Bn - -
10 Oculis Holding AG 8.23 Bn 7.92 Bn - 251.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 251.12 Mn
Dec 31, 2025 245.32 Mn
Sep 30, 2025 163.26 Mn
Jun 30, 2025 172.84 Mn
Mar 31, 2025 180.88 Mn
Dec 31, 2024 83.77 Mn
Sep 30, 2024 109.91 Mn
Jun 30, 2024 124.76 Mn
Mar 31, 2024 90.55 Mn
Dec 31, 2023 105.66 Mn
Sep 30, 2023 119.56 Mn
Jun 30, 2023 130.34 Mn
Dec 31, 2022 -101.72 Mn
Dec 31, 2021 -66.11 Mn